Studies Show Vaping After Quitting Smoking Carries Health Risks, But Remains Safer Than Continued Smoking
A large South Korean study found that ex-smokers who vape have a 56% higher risk of lung cancer compared to those who quit completely, while the FDA approved fruit-flavored e-cigarettes despite data showing they offer no significant advantage over tobacco-flavored versions. Both findings underscore that while vaping is less harmful than smoking, it is not risk-free and complete cessation of all nicotine products remains the safest option. The research highlights ongoing questions about e-cigarette safety and regulatory decisions as vaping becomes more common among people attempting to quit smoking.
A study of 4.5 million South Korean smokers tracked from 2018 to 2023 found that ex-smokers who continued vaping had a 56% higher risk of lung cancer death compared to those who quit smoking entirely, though the risk remained substantially lower than for current smokers. The research identified several biological mechanisms potentially linking vaping to cancer risk, including DNA damage, oxidative stress, and inflammation in respiratory tissue. Separately, the FDA recently approved fruit-flavored e-cigarettes as a less-harmful alternative to traditional cigarettes, but an agency memo revealed that the approved products showed no statistically significant advantage over tobacco-flavored versions in helping smokers quit. Experts emphasize that while these findings raise concerns about vaping's long-term safety, quitting smoking—even with e-cigarette assistance—remains far safer than continued smoking, and complete cessation of all nicotine products offers the greatest protection. The studies underscore the need for longer-term research and more cautious regulatory approaches to e-cigarette authorization.
What's missing
The New Scientist article notes that the South Korean study could not prove causation and that further research outside South Korea is needed; the study's reliance on self-reported vaping use and potential confounding variables are not explicitly discussed in either source.
What different sources said
- AP NewsCenter
FDA’s e-cigarette authorization: Fruity vapes not significantly better than tobacco ones
- New ScientistCenter
Ditching cigarettes for vapes may curb the cancer benefits of quitting
- AP NewsCenter
FDA’s e-cigarette authorization: Fruity vapes not significantly better than tobacco ones
Related
CAR T-cell therapy puts lupus into remission in pioneering NHS trial
Five lupus patients in England have achieved remission after receiving CAR T-cell therapy, a genetically modified immune treatment, in an early NHS trial at University College London Hospitals. The therapy works by engineering patients' own T cells to destroy malfunctioning B cells, effectively resetting the immune system, and patients have remained well for over 18 months without lupus medication. If confirmed in larger studies, this could represent a potential cure for lupus and may be applicable to other autoimmune diseases like multiple sclerosis and rheumatoid arthritis.
UK to Offer Meningitis B Vaccine to Million Young People Following Outbreak
The UK government has announced a one-off vaccination programme offering two doses of the meningitis B vaccine to approximately one million teenagers in their final school year and young people under 25 starting university, beginning in late July 2026. The decision follows an unprecedented outbreak in Kent and clusters in Dorset and Berkshire that resulted in three deaths, with all cases covered by the Bexero vaccine. The programme aims to protect those at highest risk during university entry, when increased social mixing and shared accommodation elevate transmission risk.
NHS Investigation Finds Gender Care Failures at Brighton GP Clinic, 78 Children Prescribed Medication Inappropriately
An NHS safety investigation found that a Brighton GP practice (WellBN) inappropriately prescribed gender-related medications to 78 children under 18 between February 2023 and December 2025, including some under age 13, often without proper face-to-face appointments or necessary medical oversight. The clinic lacked qualified clinicians and specialist support, failed to conduct required blood tests, and provided treatment that fell "far short of what could be considered safe or appropriate." NHS England has suspended prescriptions to children at the clinic and referred clinicians to medical regulators, highlighting systemic failures in a service created to address long waiting times for specialist gender care.